Understanding treatment options for kidney disease

Patients with end-stage renal disease (ESRD) and their families are encouraged to understand available treatment options and consult healthcare professionals to make informed decisions as chronic kidney disease (CKD) remains a significant health concern in the Philippines.
CKD often goes undetected during its early stages because symptoms may not be noticeable. In some patients, the condition progresses to Stage 5 CKD, or ESRD, when the kidneys can no longer adequately perform their essential functions.
Treatment options include kidney transplantation, dialysis and comprehensive conservative care, with palliative support when appropriate. The choice depends on the patient’s overall health, medical condition, lifestyle and preferences.
Kidney transplantation is often considered the preferred option for eligible patients because it may improve quality of life and long-term outcomes. However, limited organ donations, waiting lists and medical eligibility requirements can delay the procedure, prompting many patients to undergo dialysis while awaiting a suitable transplant.
Dialysis helps remove waste products and excess fluid from the body. Its two main forms are peritoneal dialysis and hemodialysis. Peritoneal dialysis uses the lining of the abdomen as a natural filter, with treatment generally performed daily through manual exchanges or an automated machine. Hemodialysis, meanwhile, filters blood through a dialysis machine and specialized filter, typically at a center several times a week.
For patients who choose not to undergo dialysis or transplantation, comprehensive conservative kidney management focuses on controlling symptoms, maintaining comfort and supporting quality of life. Palliative care may also be provided alongside other treatments.
According to local data cited by NephroPlus Philippines, approximately 94 percent of Filipino ESRD patients receive center-based hemodialysis, making it the country’s most commonly used treatment option.
NephroPlus Philippines, part of Asia’s largest dialysis network, said it continues to expand its nationwide network of dialysis centers, particularly in underserved communities, to help reduce travel burdens for patients requiring regular treatment.
The company also highlighted its standardized clinical practices and continuing training for healthcare professionals as part of its efforts to maintain quality and safety across its facilities.
It also offers the NephroPlus Guest App, which allows patients to track fluid intake and earn wellness tokens that can be redeemed for vouchers from participating brands. The app is intended to encourage self-management between dialysis sessions and complement guidance from healthcare teams.




